Pictet Asset Management Holding Sa Arbutus Biopharma Corp Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 23,927 shares of ABUS stock, worth $103,603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,927
Previous 23,927
-0.0%
Holding current value
$103,603
Previous $83,000
12.05%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ABUS
# of Institutions
183Shares Held
118MCall Options Held
1MPut Options Held
478K-
Morgan Stanley New York, NY24.2MShares$105 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$57.8 Million14.31% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$50 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY10.4MShares$45.2 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$39.3 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $649M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...